Cargando…
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
INTRODUCTION: The cognitive safety of monoclonal antibody proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) has been established in clinical trials, but not yet in real-world observational studies. We assessed the cognitive function in patients initiating PCSK9i, and differences in c...
Autores principales: | Seijas-Amigo, Jose, Mauriz-Montero, Mª José, Suarez-Artime, Pedro, Gayoso-Rey, Mónica, Estany-Gestal, Ana, Casas-Martínez, Antonia, González-Freire, Lara, Rodriguez-Vazquez, Ana, Pérez-Rodriguez, Natalia, Villaverde-Piñeiro, Laura, Castro-Rubinos, Concepción, Espino-Faisán, Esther, Rodríguez-Mañero, Moisés, Cordero, Alberto, González-Juanatey, José R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462529/ https://www.ncbi.nlm.nih.gov/pubmed/37612529 http://dx.doi.org/10.1007/s40256-023-00604-6 |
Ejemplares similares
-
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
por: Seijas-Amigo, Jose, et al.
Publicado: (2022) -
Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9
por: Seijas-Amigo, Jose, et al.
Publicado: (2022) -
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
por: Salgado-Barreira, Angel, et al.
Publicado: (2023) -
Omentin protects H9c2 cells against docetaxel cardiotoxicity
por: Lage, Ricardo, et al.
Publicado: (2019) -
Changes in autonomic response during cardioneuroablation in an elderly patient with carotid sinus syndrome
por: Minguito-Carazo, Carlos, et al.
Publicado: (2022)